Two studies presented at the annual Conference on Retroviruses and Opportunistic Infections showed that a reformulated, long-acting injectable drug called GSK744 gave 100% protection to macaques from the hybrid simian/ human AIDS virus for up to three months against infection. Researchers from the University of Rockefeller and the Centers for Disease Control and Prevention tested the drug in a separate study in different doses on animal subjects, which gained similar positive results. Researchers expect to launch trials in the coming months to test if the drug will work on humans.
Long-acting shot prevents HIV infection in animal studies
SmartBrief Job Listings for Education
|CONTRACT - Education Consultants||
|East Coast, Phoenix, Los Angeles, SL_Multiple Locations|
|Inside Sales Representative||
|Multiple Locations, SL_Multiple Locations|
|Product Marketing Manager||
|Business Development Analyst||
Insight Education Group
|Los Angeles, CA|
|Instructional Designer, ESL||
Imagine Learning, Inc.